Clinical Trials

    Showing 1 - 3 of 3 Kidney Transplant

    A Double-blind, Randomized, Controlled Dose Escalation Trial of Autologous Mesenchymal Stromal Cells in Living Donor Kidney Transplant Recipients

    Status: Enrolling

    Investigator: Ahmed Gaber

    Study Coordinator:

    Phone:

    Kidney transplantation is a good treatment option for people with kidney disease. However, there is still much to learn about how to best care for the transplanted kidney and keep it functioning for a long time. Transplant recipients receive inductio... Read more >

    A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

    Status: Enrolling

    Investigator: Ahmed Gaber

    Study Coordinator: Jack Curtis

    Phone: 913.486.9249

    This is a randomized, double-blind, placebo-controlled trial in de novo kidney transplant patients to determine if the addition of fingolimod (brand name Gilenya®, candidate name- FTY720) on the background of standard immunosuppression will prevent e... Read more >

    An Open-Label, Controlled, Randomized Phase 3 Trial Evaluating 12-Month Kidney Function in Highly Sensitized (cPRA =99.9%) Kidney Transplant Patients with Positive Crossmatch Against a Deceased Donor, Using Imlifidase with Standard of Care

    Status: Open Not Enrolling

    Investigator: Ahmed Gaber

    Study Coordinator: Beatriz Efron

    Phone: 713.363.8890

    An open-label, controlled, randomized Phase 3 trial evaluating 12-month kidney function in highly sensitized (cPRA =99.9%) kidney transplant patients with positive crossmatch against a deceased donor, comparing desensitization using imlifidase with s... Read more >